Posology of Antidiabetic Drugs and Insulins: A Review of Standard Textbooks
DOI:
https://doi.org/10.59793/kb5rr979Keywords:
Posology,, antidiabetic drugs,, postprandial hyperglycemiaAbstract
The aim of this bibliographic review is to assess whether standard pharmacology, endocrinology and diabetology
textbooks adequately mention the details regarding timings of administration, frequency and dose of various oral and
injectable antidiabetic drugs. Material and methods: Four standard textbooks of pharmacology, two of diabetology and
three of endocrinology were assessed for the published information regarding dose, timing and frequency of antidiabetic
drugs. Results: Various omissions and contraindications were found in the coverage of glucose-lowering drugs in standard
textbooks. Proper timing and frequency of administration of sulfonylureas, thiazolidinediones, SGLT2 inhibitors, GLP-1
receptor agonists and DPP-4 inhibitors have been omitted in majority of the textbooks. Conclusions: This article stresses
upon the need of a uniform source of information for providing adequate and standardized knowledge regarding timing,
frequency and dose of antidiabetic drugs.
Downloads
Published
Issue
Section
License
Copyright (c) 2026 Indian Journal Of Clinical Practice

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
All open access articles published in IJCP are distributed under the terms of the CC BY-NC 4.0 license (Creative Commons Attribution-Non-Commercial 4.0 International Public License). This license permits unrestricted use, distribution, and reproduction of the articles in any medium for non-commercial purposes, provided that: The original authorship is properly and fully attributed. The IJCP is cited as the original place of publication with correct citation details. If an original work is reproduced or disseminated in part or as a derivative work, this must be clearly indicated. No articles are reproduced for commercial use without prior consent from the IJCP. All licensing requests and permissions for commercial use will be managed by the Publisher.






